These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24594125)

  • 1. [Reversibility of hepatic fibrosis].
    van der Meer AJ; Sonneveld M; Schouten JN; Janssen HL
    Ned Tijdschr Geneeskd; 2014; 158():A6790. PubMed ID: 24594125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of hepatitis B virus cirrhosis after therapy: who and why?
    Bedossa P
    Liver Int; 2015 Jan; 35 Suppl 1():78-81. PubMed ID: 25529091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
    Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
    J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: the reversibility of cirrhosis.
    Sohrabpour AA; Mohamadnejad M; Malekzadeh R
    Aliment Pharmacol Ther; 2012 Nov; 36(9):824-32. PubMed ID: 22966946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Regression of Cirrhosis.
    Saffioti F; Pinzani M
    Dig Dis; 2016; 34(4):374-81. PubMed ID: 27170391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
    Kamal S; Khan MA; Seth A; Cholankeril G; Gupta D; Singh U; Kamal F; Howden CW; Stave C; Nair S; Satapathy SK; Ahmed A
    Am J Gastroenterol; 2017 Oct; 112(10):1495-1505. PubMed ID: 28585556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global impact of hepatic fibrosis and end-stage liver disease.
    Lim YS; Kim WR
    Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rating fibrosis progression in chronic liver diseases.
    Rosenberg WM
    J Hepatol; 2003 Mar; 38(3):357-60. PubMed ID: 12586303
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversibility of hepatic fibrosis and cirrhosis--is it all hype?
    Friedman SL
    Nat Clin Pract Gastroenterol Hepatol; 2007 May; 4(5):236-7. PubMed ID: 17476207
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of liver cirrhosis: current evidence and expectations.
    Jung YK; Yim HJ
    Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of histological features in chronic hepatitis C.
    Jármay K; Karácsony G; Ozsvár Z; Nagy I; Lonovics J; Schaff Z
    Hepatogastroenterology; 2002; 49(43):239-43. PubMed ID: 11941964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus.
    Xu F; Moorman AC; Tong X; Gordon SC; Rupp LB; Lu M; Teshale EH; Spradling PR; Boscarino JA; Trinacty CM; Schmidt MA; Holmberg SD; ; Holmberg SD; Teshale EH; Spradling PR; Moorman AC; Xing J; Tong X; Xu F; Gordon SC; Nerenz DR; Lu M; Lamerato L; Wang Y; Rupp LB; Akkerman N; Oja-Tebbe N; Zhang T; Li J; Sitarik A; Larkin D; Boscarino JA; Daar ZS; Curry PJ; Smith RE; Vijayadeva V; Parker JV; Schmidt MA; Donald JL; Keast EM
    Clin Infect Dis; 2016 Feb; 62(3):289-297. PubMed ID: 26417034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cirrhosis and liver fibrosis are potentially reversible].
    Hansen T; Christensen E
    Ugeskr Laeger; 2015 Nov; 177(48):V06150527. PubMed ID: 26617169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver fibrosis in hepatitis B: a dynamic process].
    Bedossa P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S103-8. PubMed ID: 21095512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Fibrosis: Emerging Therapies.
    Friedman SL
    Dig Dis; 2015; 33(4):504-7. PubMed ID: 26159266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background.
    Bortolotti F; Guido M
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):401-6. PubMed ID: 17414134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research advances in the treatment of hepatic fibrosis].
    Xia L; Yang CQ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):566-570. PubMed ID: 29056004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?
    van der Meer AJ
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):559-66. PubMed ID: 25579804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of etiological treatment on prognosis.
    Su CW; Yang YY; Lin HC
    Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.
    Hytiroglou P; Theise ND
    Virchows Arch; 2018 Jul; 473(1):15-22. PubMed ID: 29589101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.